dichlororibofuranosylbenzimidazole has been researched along with Arthritis, Rheumatoid in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zatsepina, OV | 1 |
| Voit, R | 1 |
| Grummt, I | 1 |
| Spring, H | 1 |
| Semenov, MV | 1 |
| Trendelenburg, MF | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Arthritis, Rheumatoid
| Article | Year |
|---|---|
The RNA polymerase I-specific transcription initiation factor UBF is associated with transcriptionally active and inactive ribosomal genes.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Cattle; Cell Line; Cell Nucleolus; Cricetinae; Dacti | 1993 |